comprehensive -WSS

comprehensive

author：fashion 2025-10-02 22:26:26 - browse：844

Launching your first clinical trial is the type of announcement most biotech executives eagerly anticipate, hoping to celebrate with employees. But for Celsius Therapeutics CEO Tariq Kassum, it’s proving to be more difficult than he anticipated.

That’s because in recent days, Celsius, based in Cambridge, Mass., has been forced to conduct a round of layoffs, sources told STAT. Kassum confirmed around 75% of Celsius’ 40-person team had been laid off, and disclosed that the biotech has also been quietly paring back its pipeline this year. It shut down almost all early-stage research projects, including pausing all of its cancer drug work, in order to conserve enough cash for the Phase 1 trial it announced this week.

“It’s an incredibly bittersweet moment.… The cognitive dissonance there is just really, really hard,” Kassum told STAT. “But I do think that you’re seeing a lot of other companies doing what we are, which is, as painful as it is, to focus on the nearest term value drivers, the things that can get to patients the quickest, and make the painful decisions that allow you to live to fight another day.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： How clinical AI models' predictive power can degrade over time

hotspot

WSS

Akero's treatment for NASH falls short in cirrhosis study

Peter Marks talks Operation Warp Speed for Rare Diseases

Diversity in medical illustrations gets boost from Chidiebere Ibe

FDA panel gives mixed vote on blood pressure devices

Takeaways from AdvaMed, the largest medical devices conference

STAT Readout Newsletter: Today in biotech, life science news

Wikipedia

comprehensive

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How should state employee insurance handle Wegovy?

Medical records are filled with copy

How doctors and nurses shape Google's AI

Medicare details structure of new drug price negotiation program

Study finds new variant for Parkinson’s in African populations

Psychedelics group wrestles with new pharma identity

Diversity in medical illustrations gets boost from Chidiebere Ibe

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Humana CEO Bruce Broussard to step down in 2024

hotspot

A revolution in caring for preterm infants

STAT Readout: Today's biotech news includes Sana and Amylyx

Feds fine Medicare Advantage plans for overcharging members

CDC advisory panel says seniors 'may' get RSV vaccine

Radiation, mainstay of cancer treatment, begins a fade

Female surgeons have lower rates of long

Wikipedia

explore

hotspot

Wikipedia